IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 20 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $254,000 | -52.6% | 1,211,604 | -42.3% | 0.00% | – |
| Q2 2018 | $536,000 | +109.4% | 2,100,508 | +105.5% | 0.00% | – |
| Q1 2018 | $256,000 | +36.9% | 1,022,104 | +73.1% | 0.00% | – |
| Q4 2017 | $187,000 | -26.4% | 590,604 | -13.2% | 0.00% | – |
| Q3 2017 | $254,000 | +126.8% | 680,404 | +417.0% | 0.00% | – |
| Q2 2017 | $112,000 | -69.8% | 131,604 | +12.7% | 0.00% | -100.0% |
| Q1 2017 | $371,000 | +85.5% | 116,804 | +19.7% | 0.00% | – |
| Q4 2016 | $200,000 | – | 97,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 86,530 | $22,000 | 0.00% |
| Virtu Financial LLC | 124,195 | $32,000 | 0.00% |
| BARCLAYS PLC | 50 | $0 | 0.00% |
| VANGUARD GROUP INC | 285,154 | $74,000 | 0.00% |
| UBS Group AG | 32,270 | $8,000 | 0.00% |
| Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
| Rehmann Capital Advisory Group | 69 | $18,000 | 0.00% |
| IFP Advisors, Inc | 95 | $0 | 0.00% |
| Jacobi Capital Management LLC | 125 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $0 | 0.00% |